Penas, F. N., Carta, D., Dmytrenko, G., Mirkin, G. A. I., Modenutti, C. P., Cevey, Á. C., . . . Goren, N. B. (2017). Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice. Web
Citación estilo ChicagoPenas, Federico Nicolás, et al. Treatment With a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-Infected Mice. 2017.
Cita MLAPenas, Federico Nicolás, et al. Treatment With a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-Infected Mice. 2017.